However, SomInaClust also prioritized driver genes that are less frequently mutated in breast cancer like AKT1 (20 out of 772 mutations) and CDKN1B (7 mutations, representing less than 1% of all mutations across samples) (Additional file 6: Figure S3A). This evidence concerns the gene AKT1 and breast carcinoma.